GRK2 Up-Regulation Creates a Positive Feedback Loop for Catecholamine Production in Chromaffin Cells

Overview

Journal Mol Endocrinol

Specialties Endocrinology
Molecular Biology

Date 2016 Feb 6

PMID 26849467

Citations 16

Authors

Malika Jafferjee

Thairy Reyes Valero

Christine Marrero

Katie A McCrink

Ava Brill

Anastasios Lymperopoulos

Affiliations

Soon will be listed here.

Abstract

Elevated sympathetic nervous system (SNS) activity aggravates several diseases, including heart failure. The molecular cause(s) underlying this SNS hyperactivity are not known. We have previously uncovered a neurohormonal mechanism, operating in adrenomedullary chromaffin cells, by which circulating catecholamine (CA) levels increase in heart failure: severe dysfunction of the adrenal α2-adrenergic receptors (ARs) due to the up-regulation of G protein-coupled receptor-kinase (GRK)-2, the kinase that desensitizes them. Herein we looked at the potential signaling mechanisms that bring about this GRK2 elevation in chromaffin cells. We found that chronic CA treatment of either PC12 or rat primary chromaffin cells can in itself result in GRK2 transcriptional up-regulation through α2ARs-Gi/o proteins-Src-ERK1/2. The resultant GRK2 increase severely enhances the α2AR desensitization/down-regulation elevating not only CA release but also CA biosynthesis, as evidenced by tyrosine hydroxylase up-regulation. Finally, GRK2 knockdown leads to enhanced apoptosis of PC12 cells, indicating an essential role for GRK2 in chromaffin cell homeostasis/survival. In conclusion, chromaffin cell GRK2 mediates a positive feedback loop that feeds into CA secretion, thereby enabling the adrenomedullary component of the SNS to turn itself on.

Citing Articles

Cyclic Adenosine Monophosphate in Cardiac and Sympathoadrenal GLP-1 Receptor Signaling: Focus on Anti-Inflammatory Effects.

Lymperopoulos A, Borges J, Stoicovy R Pharmaceutics. 2024; 16(6).

PMID: 38931817 PMC: 11206770. DOI: 10.3390/pharmaceutics16060693.

Differential Modulation of Catecholamine and Adipokine Secretion by the Short Chain Fatty Acid Receptor FFAR3 and α-Adrenergic Receptors in PC12 Cells.

Nagliya D, Lopez T, Del Calvo G, Stoicovy R, Borges J, Suster M Int J Mol Sci. 2024; 25(10).

PMID: 38791266 PMC: 11120680. DOI: 10.3390/ijms25105227.

Nicotine Diminishes Alpha2-Adrenergic Receptor-Dependent Protection Against Oxidative Stress in H9c2 Cardiomyocytes.

Del Calvo G, Pollard C, Lopez T, Borges J, Suster M, Lymperopoulos A Drug Des Devel Ther. 2024; 18:71-80.

PMID: 38229917 PMC: 10790636. DOI: 10.2147/DDDT.S432453.

RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting.

Lymperopoulos A, Borges J, Stoicovy R Biochem Pharmacol. 2023; 218:115904.

PMID: 37922976 PMC: 10841918. DOI: 10.1016/j.bcp.2023.115904.

GTPγS Assay for Measuring Agonist-Induced Desensitization of Two Human Polymorphic Alpha-Adrenoceptor Variants.

Borges J, Carbone A, Cora N, Sizova A, Lymperopoulos A Methods Mol Biol. 2022; 2547:267-273.

PMID: 36068469 DOI: 10.1007/978-1-0716-2573-6_12.

References

Lymperopoulos A, Rengo G, Koch W . Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res. 2013; 113(6):739-53. PMC: 3843360. DOI: 10.1161/CIRCRESAHA.113.300308. View

Llorente J, Lowe J, Sanderson H, Tsisanova E, Kelly E, Henderson G . μ-Opioid receptor desensitization: homologous or heterologous?. Eur J Neurosci. 2012; 36(12):3636-42. PMC: 3527680. DOI: 10.1111/ejn.12003. View

Lymperopoulos A, Rengo G, Koch W . GRK2 inhibition in heart failure: something old, something new. Curr Pharm Des. 2012; 18(2):186-91. DOI: 10.2174/138161212799040510. View

Currie K . Inhibition of Ca2+ channels and adrenal catecholamine release by G protein coupled receptors. Cell Mol Neurobiol. 2010; 30(8):1201-8. PMC: 3028936. DOI: 10.1007/s10571-010-9596-7. View

Nguyen K, Kassimatis T, Lymperopoulos A . Impaired desensitization of a human polymorphic α2B-adrenergic receptor variant enhances its sympatho-inhibitory activity in chromaffin cells. Cell Commun Signal. 2011; 9(1):5. PMC: 3041786. DOI: 10.1186/1478-811X-9-5. View

Penn R, Pronin A, Benovic J . Regulation of G protein-coupled receptor kinases. Trends Cardiovasc Med. 2001; 10(2):81-9. DOI: 10.1016/s1050-1738(00)00053-0. View

Hein L, Altman J, Kobilka B . Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature. 2000; 402(6758):181-4. DOI: 10.1038/46040. View

Lymperopoulos A, Rengo G, Gao E, Ebert S, Dorn 2nd G, Koch W . Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction. J Biol Chem. 2010; 285(21):16378-86. PMC: 2871505. DOI: 10.1074/jbc.M109.077859. View

Uhlen S, Dambrova M, Nasman J, Schioth H, Gu Y, Wikberg J . [3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine. Eur J Pharmacol. 1998; 343(1):93-101. DOI: 10.1016/s0014-2999(97)01521-5. View

10.

Zheng H, Loh H, Law P . Beta-arrestin-dependent mu-opioid receptor-activated extracellular signal-regulated kinases (ERKs) Translocate to Nucleus in Contrast to G protein-dependent ERK activation. Mol Pharmacol. 2007; 73(1):178-90. PMC: 2253657. DOI: 10.1124/mol.107.039842. View

11.

Lymperopoulos A, Rengo G, Koch W . Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation. Trends Mol Med. 2007; 13(12):503-11. DOI: 10.1016/j.molmed.2007.10.005. View

12.

Williams N, Zhong H, Minneman K . Differential coupling of alpha1-, alpha2-, and beta-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells. J Biol Chem. 1998; 273(38):24624-32. DOI: 10.1074/jbc.273.38.24624. View

13.

Floras J . The "unsympathetic" nervous system of heart failure. Circulation. 2002; 105(15):1753-5. DOI: 10.1161/01.cir.0000013788.71817.16. View

14.

Schneider J, Lother A, Hein L, Gilsbach R . Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis. Basic Res Cardiol. 2011; 106(4):591-602. DOI: 10.1007/s00395-011-0166-z. View

15.

Hein L . Adrenoceptors and signal transduction in neurons. Cell Tissue Res. 2006; 326(2):541-51. DOI: 10.1007/s00441-006-0285-2. View

16.

Salazar N, Vallejos X, Siryk A, Rengo G, Cannavo A, Liccardo D . GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility. Cell Commun Signal. 2013; 11:64. PMC: 3846709. DOI: 10.1186/1478-811X-11-64. View

17.

Luttrell D, Luttrell L . Not so strange bedfellows: G-protein-coupled receptors and Src family kinases. Oncogene. 2004; 23(48):7969-78. DOI: 10.1038/sj.onc.1208162. View

18.

Aggarwal A, Esler M, Lambert G, Hastings J, Johnston L, Kaye D . Norepinephrine turnover is increased in suprabulbar subcortical brain regions and is related to whole-body sympathetic activity in human heart failure. Circulation. 2002; 105(9):1031-3. DOI: 10.1161/hc0902.105724. View

19.

Daaka Y, Luttrell L, Lefkowitz R . Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature. 1997; 390(6655):88-91. DOI: 10.1038/36362. View

20.

Cohn J, Pfeffer M, Rouleau J, Sharpe N, Swedberg K, Straub M . Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON). Eur J Heart Fail. 2003; 5(5):659-67. DOI: 10.1016/s1388-9842(03)00163-6. View